Influence of Tskaltubo Low-Radon Nitrogen Mineral Baths on Erythrocyte Biophysical Parameters and Microcirculation in Osteoarthritis: A Prospective Clinical Study
DOI:
https://doi.org/10.5281/zenodo.19076785Keywords:
Osteoarthritis, Low-radon mineral baths, Erythrocyte rheology, Electrokinetic potential, Ultrasonic resistance, Microcirculation, BalneotherapyAbstract
Background:
Osteoarthritis (OA) is a leading cause of disability worldwide and is increasingly recognized as a multifactorial disease involving inflammatory, metabolic, biomechanical, and microvascular mechanisms [1–4]. Emerging evidence suggests that hemorheological disturbances, including impaired erythrocyte membrane stability and increased aggregation, may contribute to tissue hypoxia and disease progression [8–10].
Objective:
To evaluate changes in erythrocyte biophysical parameters in patients with osteoarthritis undergoing a standardized course of Tskaltubo low-radon nitrogen mineral baths and to explore their potential role in improving microcirculatory function during rehabilitation.
Methods:
This prospective observational clinical study included 165 patients with radiographically confirmed osteoarthritis (Kellgren–Lawrence stages I–IV; mean age 58.4 ± 6.7 years). Participants underwent 22–25 flow-through isothermal mineral baths (34–35 °C; 20 minutes per session). Erythrocyte count, hemoglobin concentration, ultrasonic resistance time (T), electrokinetic potential (EKP), and aggregation activity (AAE) were measured before and after treatment. Ten age-matched healthy individuals served as controls. Statistical analysis included paired t-tests, one-way ANOVA, Pearson correlation analysis, and effect size estimation with 95% confidence intervals.
Results:
At baseline, OA patients demonstrated reduced ultrasonic resistance (mean difference −2.4 min; 95% CI −3.6 to −1.2; p = 0.021), decreased electrokinetic potential (mean difference −3.1 mV; 95% CI −4.9 to −1.2; p = 0.008), and increased aggregation activity (mean difference +5.4%; 95% CI 2.1–8.7; p = 0.012) compared with controls. Following treatment, electrokinetic potential increased significantly (mean difference 2.3 mV; 95% CI 0.8–3.8; p = 0.006), corresponding to an 18.4% relative increase. Ultrasonic resistance increased by 14.7% (p = 0.011), and aggregation activity decreased by 16.2% (p = 0.004). Improvements were more pronounced in patients with synovitis. Changes in electrokinetic potential correlated with pain reduction (r = 0.42; p = 0.018).
Conclusion:
Tskaltubo low-radon nitrogen mineral baths were associated with improvements in erythrocyte biophysical parameters in osteoarthritis. These findings suggest that modulation of erythrocyte rheology may represent a clinically relevant physiological pathway contributing to improved microcirculatory function and rehabilitation outcomes. Further randomized controlled studies incorporating molecular biomarkers and long-term follow-up are warranted.
Keywords:
Osteoarthritis; Balneotherapy; Radon therapy; Erythrocyte rheology; Microcirculation; Hemorheology; Rehabilitation
References
1. Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019;393(10182):1745–1759. https://doi.org/10.1016/S0140-6736(19)30417-9
2. GBD 2019 Diseases and Injuries Collaborators. Global burden of osteoarthritis 1990–2019. Lancet Rheumatol. 2021;3(3):e490–e502. https://doi.org/10.1016/S2665-9913(20)30446-8
3. Loeser RF, Collins JA, Diekman BO. Aging and osteoarthritis. Nat Rev Rheumatol. 2016;12(7):412–420. https://doi.org/10.1038/nrrheum.2016.65
4. Mobasheri A, Batt M. An update on osteoarthritis pathophysiology. Ann Phys Rehabil Med. 2016;59(5–6):333–339. https://doi.org/10.1016/j.rehab.2016.07.004
5. Feng Z, Wang S, Xu W, et al. Hypoxia and osteoarthritis. Front Cell Dev Biol. 2021;9:673918. https://doi.org/10.3389/fcell.2021.673918
6. Lories RJ, Luyten FP. Bone–cartilage unit in osteoarthritis. Nat Rev Rheumatol. 2011;7(1):43–49. https://doi.org/10.1038/nrrheum.2010.197
7. Blanco FJ, Rego I, Ruiz-Romero C. Mitochondrial dysfunction in osteoarthritis. Nat Rev Rheumatol. 2011;7(3):161–169. https://doi.org/10.1038/nrrheum.2010.213
8. Baskurt OK, Meiselman HJ. Blood rheology and hemodynamics. Semin Thromb Hemost. 2003;29(5):435–450. https://doi.org/10.1055/s-2003-44551
9. Baskurt OK, Nemeth N. Red blood cell deformability and disease. Clin Hemorheol Microcirc. 2022;80(1):1–18. https://doi.org/10.3233/CH-211234
10. Mohandas N, Gallagher PG. Red cell membrane biology. Blood. 2008;112(10):3939–3948. https://doi.org/10.1182/blood-2008-07-161166
11. Tenti S, Cheleschi S, Galeazzi M, Fioravanti A. Balneotherapy for osteoarthritis: systematic review. Clin Rheumatol. 2023;42(2):345–358. https://doi.org/10.1007/s10067-022-06489-3
12. Protano C, Fontana M, De Giorgi A, et al. Balneotherapy in musculoskeletal disorders. Rheumatol Int. 2023;43(7):1597–1610. https://doi.org/10.1007/s00296-023-05234-8
13. Bannuru RR, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2019;27(11):1578–1589. https://doi.org/10.1016/j.joca.2019.06.011
14. Becker BE. Aquatic therapy: scientific foundations and clinical rehabilitation applications. PM R. 2009;1(9):859–872. https://doi.org/10.1016/j.pmrj.2009.05.017
15. Forestier R, et al. Spa therapy in osteoarthritis. Ann Rheum Dis. 2010;69(4):660–665. https://doi.org/10.1136/ard.2009.113209
16. Sakellariou GT, et al. Balneotherapy randomized trial. Clin Rehabil. 2016;30(11):1092–1100. https://doi.org/10.1177/0269215515600532
17. Rödel F, et al. Modulation of inflammatory immune reactions by low-dose ionizing radiation. Curr Med Chem. 2012;19(12):1741–1750. https://doi.org/10.2174/092986712800099866
18. Feinendegen LE. Evidence for beneficial low level radiation effects. Br J Radiol. 2005;78(925):3–7. https://doi.org/10.1259/bjr/63353075
19. Guéguen Y, Bontemps A, Ebrahimian TG. Adaptive responses to low doses of radiation. Cell Mol Life Sci. 2019;76(7):1255–1273. https://doi.org/10.1007/s00018-018-2987-5
20. Kensler TW, Wakabayashi N, Biswal S. Nrf2 pathway. Annu Rev Pharmacol Toxicol. 2007;47:89–116. https://doi.org/10.1146/annurev.pharmtox.46.120604.141046
21. Azzam EI, et al. Low-dose radiation and NF-κB activation. Radiat Res. 2004;161(3):349–358. https://doi.org/10.1667/RR3153
22. Löbrich M, Jeggo PA. DNA repair pathways. Nat Rev Mol Cell Biol. 2007;8(6):465–476. https://doi.org/10.1038/nrm2197
23. UNSCEAR. Sources and effects of ionizing radiation. United Nations; 2008
24. ICRP. The 2007 Recommendations of the International Commission on Radiological Protection. Ann ICRP. 2007;37(2–4)
25. WHO. WHO handbook on indoor radon. Geneva: World Health Organization; 2009
26. Kendall GM, Smith TJ. Radon elimination kinetics. Radiat Prot Dosimetry. 2002;102(4):321–326
27. Clapham DE. Calcium signaling. Cell. 2007;131(6):1047–1058. https://doi.org/10.1016/j.cell.2007.11.028
28. Berridge MJ. Calcium signalling and inflammation. Nature. 2016;529(7586):163–170. https://doi.org/10.1038/nature16562
29. Rühle PF, et al. Low-dose radiation and immune modulation. Front Immunol. 2015;6:486. https://doi.org/10.3389/fimmu.2015.00486
30. Cuttler JM. Low-dose radiation in medicine. Dose Response. 2017;15(1):1559325817694943. https://doi.org/10.1177/1559325817694943
31. Nasermoaddeli A, Kagamimori S. Balneotherapy review. J Epidemiol. 2005;15(6):235–245
32. Fioravanti A, et al. Spa therapy in rheumatic disease. Clin Exp Rheumatol. 2011;29(Suppl 64):S73–S80
33. Felson DT. Clinical practice: knee osteoarthritis. N Engl J Med. 2006;354(8):841–848. https://doi.org/10.1056/NEJMcp051726
34. Sellam J, Berenbaum F. Pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2010;6(11):625–635
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Giorgi Shavianidze, Marina Shavianidze, Giorgi Lomidze

This work is licensed under a Creative Commons Attribution 4.0 International License.
This article is published open access under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence.
You are free to: share and adapt the work for any purpose, even commercially.
Conditions: provide appropriate credit to the authors and the Georgian Medical Journal (GMJ), link to the licence, and indicate if changes were made. Do not apply legal terms or technological measures that legally restrict others from doing anything the licence permits.
Licence: creativecommons.org/licenses/by/4.0 · Legal code: creativecommons.org/licenses/by/4.0/legalcode
Third-party material. Images or other content credited to a third party are not covered by CC BY 4.0; permission must be obtained from the rights holder for reuse beyond statutory exceptions.
Authors' rights. Authors retain copyright. First publication rights are granted to GMJ.
Data and code. Where provided, datasets or code may carry their own licences; please follow the licence stated in the article or repository record.




















